Haematopoietic progenitor cell transplantation in adults with symptomatic sickle cell disease: the time has arrived

Br J Haematol. 2021 Feb;192(4):678-680. doi: 10.1111/bjh.17309. Epub 2021 Jan 22.

Authors

Mitchell S Cairo¹, Bipin N Savani²

Affiliations

¹ Maria Fareri Children's Hospital, Westchester Medical Center (WMC), New York Medical College, New York, NY, USA.
² Division of Hematology and Oncology, Vanderbilt University Medical Center and Veterans Affairs Medical Center, Nashville, TN, USA.

PMID: 33482009
DOI: 10.1111/bjh.17309

No abstract available

Keywords: Hematopoietic progenitor cell transplantation; alemtuzumab; non-myeloablative conditioning; symptomatic sickle cell disease.

Publication types

Comment

MeSH terms

Adult
Anemia, Sickle Cell* / therapy
HLA Antigens
Hematopoietic Stem Cell Transplantation*
Hematopoietic Stem Cells
Humans
Transplantation Conditioning

Substances

HLA Antigens